Today, Not Someday
September is Pulmonary Fibrosis Awareness Month. This year's theme: "Today, not someday." Tomorrow the Pulmonary Clinical Trials Workshop presents a webinar on recruiting trials. Ifetroban. Nerandomilast. Inhaled treprostinil. UCSF running multi-cause fibrosis studies. United Therapeutics showing positive ERS 2026 data. I'll watch it. Take notes. Track which trials are recruiting and what the inclusion criteria look like. Knowing I won't qualify for any of them. The Timeline That Doesn't Fit Terminal pulmonary fibrosis. Diagnosed July 2024. Also bronchiectasis, COPD, pulmonary sarcoidosis, hEDS. Autistic, ADHD. 52 years old. That's not a trial subject. That's a comorbidity pile that makes the data unusable. Clinical trials need clean populations. One disease, minimal confounding factors, predictable progression. You can't measure a fibrosis drug's effect when the patient also has COPD flares, EDS complications, and sarcoidosis inf...